Cannabis Law Report

AUGUST 23, 2022

A panel of Commonwealth Court judges has ordered the Wolf administration to reveal how many medical marijuana patients have received approval from a doctor to use cannabis for opioid addiction treatment. Qualifying conditions include anxiety disorders, severe chronic pain and epilepsy.

Data 52

Data Treatment Patients Chronic Pain 52

TheAnswerPage

JUNE 10, 2021

A seizure disorder is a qualifying condition in many medical marijuana state programs. According to a presentation at the 2014 annual meeting of the American Epilepsy Society, an increasing dose of CBD was associated with significant increases in serum levels of topiramate, rufinamide, and N-desmethylclobazam. See the Answer.

Epilepsy 52

Epilepsy Programs Treatment CBD 52

MMJ Recs

AUGUST 5, 2021

Missouri’s new medical marijuana program is providing massive value to the growing number of MMJ patients in the state. Missouri residents are getting to enjoy hugely improved quality of life thanks to the rejuvenating effects of MMJ treatment. How Do You Get A Missouri MMJ Card In 2021? Best Dispensaries In Missouri In 2021.

Dispensary 52

Dispensary Chronic Pain Treatment Patients 52

The Cannigma

JULY 12, 2022

Alabama law does not allow the consumption, possession, or cultivation of marijuana for recreational purposes, but has approved the establishment of a medical marijuana program in February 2021. The same bill was introduced in 2021 but failed in the Senate Chamber. Alabama medical cannabis program.

Legalization 122

Legalization Chronic Pain Programs Treatment 122

Cannabis Law Report

DECEMBER 3, 2021

Extended Duration Safety and Efficacy of Adjunctive Ganaxolone Treatment in Patients with CDKL5 Deficiency Disorder: 8-Month Minimum Open-Label Extension Follow-up. Ganaxolone Treatment in Patients with CDKL5 Deficiency Disorder with Comorbid Lennox-Gastaut Syndrome: A Post-hoc Analysis from the Marigold Study. change in MMSF).

Epilepsy 52

Epilepsy Pharmaceutical Data Clinical Trials 52

SpeedWeed

JUNE 14, 2021

State officials tasked with overseeing Ohio’s medical marijuana program approved last week the addition of three health conditions that qualify a patient to use cannabis medicinally. The addition of all three, new, medical conditions to the Ohio Medical Marijuana Control Program (OMMCP) is effective immediately. View original article.

Conditions 40

Conditions Programs Therapy Patients 40

Cannabis Law Report

SEPTEMBER 1, 2022

AUSTIN, Texas, August 31, 2022 –( BUSINESS WIRE )–As Pain Awareness Month begins, Texas Original is calling on Texas’ legislature to add chronic pain as a qualifying condition to the state’s Compassionate Use Program (CUP). According to a 2021 Harm Reduction Journal study , 38.1% An additional 45.9%

Chronic Pain 52

Chronic Pain Programs Patients Conditions 52

Puff Puff Post

DECEMBER 28, 2018

The Current Treatments for Autism. Most education-based autism treatment is focused on teaching developing children self-care, communicative, and social skills. No single program or treatment is best, and specially tailored treatments based off the child’s needs are found to be most effective.

Treatment 76

Treatment Oil CBD Therapy 76

Puff Puff Post

OCTOBER 3, 2019

Previous success from treating epilepsy with Cannabinoids now motivates doctors to investigate the plant’s effectiveness in treating symptoms of autism. Eric Hollander, director of the Autism and Spectrum Program and Anxiety and Depression Program at Montefiore Hospital.

Research and Development 94

Research and Development Epilepsy Clinical Trials Treatment 94

The Cannigma

JULY 5, 2022

Georgia has a limited medical program but doesn’t consider itself a “medical marijuana” state as growing, possessing, or smoking any form of the plant is still illegal. The program was legalized in 2015 and patients with qualifying conditions can get a prescription for up to 20oz of low THC oil, capsules, patches, or lotion.

Law 96

Law Decriminalization Programs Patients 96

Cannabis Law Report

JULY 26, 2021

SciSparc intends to evaluate the efficacy, safety and tolerability of its Proprietary Cannabinoid-Based Treatment- SCI-110. TEL AVIV, Israel , July 26, 2021 /PRNewswire/ — SciSparc Ltd. In addition, SciSparc had established its supply chain infrastructure for the manufacturing and delivering of the SCI-110 drug.

Research and Development 105

Research and Development Supply Chain Pharmaceutical Treatment 105

The Cannigma

SEPTEMBER 28, 2021

While the country has a limited medical cannabis program in place, the Emerald Isle still lags behind many countries in Europe when it comes to cannabis legalization. A poll in May 2021 found that nearly 40% of Irish citizens support legalizing cannabis for recreational use, and over 90% support the legalization of medical marijuana.

Law 61

Law Marijuana Treatment Epilepsy 61

Cannabis Law Report

AUGUST 31, 2022

AUSTIN, Texas–(BUSINESS WIRE)–As Pain Awareness Month begins, Texas Original is calling on Texas’ legislature to add chronic pain as a qualifying condition to the state’s Compassionate Use Program (CUP). According to a 2021 Harm Reduction Journal study , 38.1% An additional 45.9% In the United States, the No.

Chronic Pain 52

Chronic Pain Programs Patients Conditions 52

The Cannigma

SEPTEMBER 28, 2021

While the country has a limited medical cannabis program in place, the Emerald Isle still lags behind many countries in Europe when it comes to cannabis legalization. A poll in May 2021 found that nearly 40% of Irish citizens support legalizing cannabis for recreational use, and over 90% support the legalization of medical marijuana.

Law 60

Law Marijuana Treatment Epilepsy 60

Veriheal

NOVEMBER 10, 2020

The experiment will only last two years long and is set to start with the first prescription in March 2021. It’s speculated that if this experimental program becomes permanent, France has the potential of becoming one of the biggest cannabis markets in the European Union.

Chronic Pain 76

Chronic Pain Pharmaceutical Patients Epilepsy 76

The Cannigma

JULY 24, 2022

South Carolina medical marijuana program. The state does not have a medical program. The most recent medical marijuana bill , introduced in 2021, would have created a program, albeit a restrictive one. The conditions are: Lennox-Gastaut Syndrome Dravet Syndrome Other severe forms of epilepsy. CBD regulations.

Law 118

Law THC Hash Oil 118

Veriheal

MARCH 1, 2021

However, the number of states that will authorize qualified patients from out-of-state medical marijuana programs is still relatively small. . That doesn’t mean you can’t access a green state’s medical marijuana programs, though. Let’s take a look at which US states that have a reciprocity program for guests that are cannabis patients.

Patients 117

Patients Marijuana Concentrates Recreational 117

Canna Law Blog

DECEMBER 16, 2021

On Monday, November 13, 2021, New York Assemblyman Pat Burke introduced medical psilocybin legislation. Qualifying medical practitioners would need to take a two-hour training course provided by the Department of Health in order to certify patients for psilocybin treatment. The bill allocates $2 million for the grant program.

Legislation 97

Legislation Treatment Therapy Conditions 97

Cannabis Law Report

FEBRUARY 19, 2022

Alabama legalized medical a medical cannabis program on May 17, 2021 when Governor Ivey signed SB 46 into law. Although medical cannabis program was signed into law last year, it has yet to be fully implemented. Since then, the legislature has passed a number of laws that have expanded the state’s medical cannabis program.

Legalization 97

Legalization Seed-To-Sale Programs Dispensary 97

Cannabis Law Report

NOVEMBER 15, 2021

Virpax” or the “Company”) (NASDAQ:VRPX), today announced its financial results for the three and nine months ended September 30, 2021, and other recent developments. “We On July 30, 2021, Virpax announced the appointment of Gerald W. On August 17, 2021, Virpax announced that it had received FDA response and guidance on AnQlar.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

MedicalJane

OCTOBER 3, 2019

Dr. Eric Hollander, the Director of the Autism and Obsessive Compulsive Spectrum Program and Anxiety and Depression Program at Montefiore Hospital, is leading the clinical trial. It is also the first FDA approval of a drug for the treatment of patients with Dravet syndrome. ” – Dr. Hollander.

Clinical Trials 74

Clinical Trials Epilepsy Pharmaceutical Treatment 74

Dykema (Cannabis Law Blog)

APRIL 20, 2023

In recent years, most major cities in Texas have launched programs and adopted policies that reduce, or even eliminate, penalties for the possession of cannabis. [ii] iv] Currently, the Act permits a qualified physician to prescribe “low-THC cannabis” (1% by weight tetrahydrocannabinol (“THC”)) for a greater number of conditions. [iv]

Law 74

Law Chronic Pain Conditions Medicine 74

Cannabis Law Report

AUGUST 2, 2021

2, 2021 /PRNewswire/ — SciSparc Ltd. OTCQB: SPRCY ) a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced positive top-line results for its proprietary compound, SCI-160 in a controlled pre-clinical trial on neuropathic and post-operative pain.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

MMJ Recs

MAY 15, 2022

This initial MMJ legislation only allowed patients suffering from intractable epilepsy to use cannabis oil. But in the years since 2017, lawmakers have steadily improved Virginia’s medical marijuana program and made it accessible to a wider range of people. Recently, Virginia legalization has changed in several ways.

Patients 52

Patients Marijuana Pharmaceutical Dispensary 52

MMJ Recs

OCTOBER 10, 2021

Large numbers of OK residents are benefitting from medical marijuana treatment, and MMJ is also bringing massive economic benefits to the Sooner State. The MMJ program in Oklahoma is liberal and patient-friendly. Since legalization, support for the OK MMJ program has grown further amongst the population.

Dispensary 52

Dispensary Treatment Chronic Pain Conditions 52

Veriheal

JULY 21, 2022

This month, patients will no longer require a medical cannabis card to participate in Virginia’s medical cannabis program. More patients in the program is better for all of the processors, but the real winners in this are the patients in having to not go through so much red tape to get enrolled into the program,” Strand said.

Access 104

Access Dispensary Patients Programs 104

Cannabis Law Report

AUGUST 17, 2021

Phase 3 planning for TrustTSC trial ongoing with first patient expected to be enrolled in Q4 2021. We look forward to initiating our Phase 3 trial and adding to the body of evidence that supports ganaxolone’s potential as an innovative treatment option for rare epilepsies.”. RADNOR, Pa.–(BUSINESS Data Highlights.

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

MMJ Recs

DECEMBER 15, 2021

Recreational marijuana became legal in New York on March 31st, 2021. In order to get a New York medical marijuana card, a person must be a resident of New York State or be temporarily residing in the state for the purpose of receiving treatment. It’s not currently possible to use an out-of-state medical marijuana card in New York.

Chronic Pain 98

Chronic Pain Dispensary Recreational Patients 98

The Cannigma

SEPTEMBER 13, 2021

In July, 2021, Israeli lawmakers rejected a bill that would have decriminalized recreational marijuana use. The medical cannabis program in Israel is not as lenient as those in many other countries, and patients typically are required to attempt other medical treatments before cannabis is approved.

Legalization 97

Legalization Decriminalization Patients Cannabis 97

MMJ Recs

JANUARY 25, 2022

Ohio’s medical marijuana program became operational in January 2019. House Bill 523, which legalized MMJ in Ohio, was passed in 2016, but regulatory red tape delayed implementation of the program. Yes, you can apply for an Ohio medical marijuana card online at the Ohio Medical Marijuana Control Program website.

Dispensary 52

Dispensary Chronic Pain Programs Treatment 52

Puff Puff Post

OCTOBER 3, 2019

Previous success from treating epilepsy with Cannabinoids now motivates doctors to investigate the plant’s effectiveness in treating symptoms of autism. Eric Hollander, director of the Autism and Spectrum Program and Anxiety and Depression Program at Montefiore Hospital.

Research and Development 40

Research and Development Epilepsy Clinical Trials Treatment 40

Veriheal

DECEMBER 28, 2021

Many of these medical conditions are featured on the list of qualifying criteria for medical cannabis programs in the 37 U.S. The report authors noted that THC, on the other hand, is touted as a popular option for alleviating the negative effects of AIDS and cancer treatment. Amyotrophic lateral sclerosis (ALS). Alzheimer’s.

Research and Development 98

Research and Development Chronic Pain Treatment Medicine 98

MMJ Recs

NOVEMBER 20, 2021

million worth of MMJ products in July 2021 alone. This means 2021 has, at the time of writing, seen revenues of over $91 million. Thousands of Missourians are now enjoying the life-enhancing benefits of medical marijuana treatment. What Are The Qualifying Conditions For Medical Marijuana Treatment In Missouri?

Dispensary 52

Dispensary Chronic Pain Treatment Conditions 52

The Cannigma

OCTOBER 20, 2021

Furthermore, in 2017 the Norwegian parliament voted in favor of a measure to decriminalize drug use, shifting the focus of drug policies towards treatment. In February 2021, Norway’s government proposed a bill to decriminalize possession, under which possession of up to 10 grams of cannabis would no longer be punishable under the law.

Legalization 59

Legalization Decriminalization Patients Medicine 59

MMJ Recs

SEPTEMBER 19, 2022

This original medical marijuana program was limited by what many patients saw as restrictively low purchase limits at Pennsylvania dispensaries. To improve the situation, in July 2021 the Governor of Pennsylvania, Tom Wolf, signed a new medical marijuana bill into law. This change in the law has had a positive effect. Crohn’s disease.

Dispensary 59

Dispensary Marijuana Treatment Patients 59

MMJ Recs

NOVEMBER 25, 2021

In July 2021, Pennsylvania Gov. This change in the law is intended to improve Pennsylvania medical marijuana patients’ access to MMJ treatment. It is important to be fully aware of PA dispensary limits when you are planning your medical marijuana treatment program and making a schedule for visiting your local dispensary.

Dispensary 52

Dispensary Treatment Patients Epilepsy 52

Cannabis Law Report

JUNE 1, 2021

Company remains on track for potential approval of Vicineum™ in the US in August 2021. Drake received her bachelor’s degree from Wichita State University and is a graduate of the Harvard Business School Executive Leadership Program. CAMBRIDGE, Mass.–(BUSINESS The Company intends to grant non-statutory stock options to Ms.

Research and Development 66

Research and Development Treatment Pharmaceutical Patients 66